Genetron Health delivers integrated end-to-end solutions for genomics research and clinical development, spanning biomarker evaluation for targeted and immunotherapies, clinical trial patient recruitment, companion diagnostic development, and CDx registration. With strategic collaborations spanning over 100 leading global biopharmaceutical firms and CROs across China and international markets, Genetron Health is a trusted partner in accelerating precision medicine. Notably, the company pioneered the first NMPA-approved bridging companion diagnostic reagent following the implementation of China’s CDx regulatory guidelines, underscoring its commitment to advancing innovative and compliant diagnostic solutions.

SERVICES OVERVIEW

01

COMPANION DIAGNOSTICS

Genetron Health’s diversified platform features innovative patented technologies such as the “One-Step Seq Method” and a nationwide marketing network, enabling our veteran registry team to provide clients with R&D of integrated companion diagnostic products and commercialization services.

MORE
Detection of early-stage hepatocellular carcinoma...
Detection of early-stage hepatocellular carcinoma...

02

CENTRAL LABORATORY TESTING

We offer a seamless one-stop solution for partners, encompassing clinical trial consulting, precision patient enrollment, and genomics testing that meets international standards like CAP, CLIA, ISO 15189. Our services also include robust data analysis, addressing all facets of drug development.

MORE

03

ONCO DATABASE

Genetron Health’s big data platform enables precision testing for early stage research and targeted screening solutions for patients covered by our biopharma partners. Our team provides industry-leading expertise and support for new drug development and validation.

MORE

Pharmaceutical Partnerships

CONTACT US

BD@genetronhealth.com